Gerald E Quirk Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

SYRS Quotes by TradingView

Gerald E Quirk is Chief Legal & Compliance Offic of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 39,757 shares of SYRS, which is worth approximately $81,899. The most recent transaction as insider was on Mar 28, 2024, when has been sold 7,046 shares (Common Stock) at a price of $5.59 per share, resulting in proceeds of $39,387. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.8K
0% 3M change
n/a 12M change
Total Value Held $81,899

Gerald E Quirk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2024
SELL
Payment of exercise price or tax liability
$39,387 $5.59 p/Share
7,046 Reduced 15.05%
39,757 Common Stock
Mar 27 2024
BUY
Exercise of conversion of derivative security
-
22,500 Added 32.47%
46,803 Common Stock
Oct 19 2023
SELL
Payment of exercise price or tax liability
$14,483 $2.1 p/Share
6,897 Reduced 22.11%
24,303 Common Stock
Oct 11 2023
BUY
Exercise of conversion of derivative security
-
22,500 Added 41.9%
31,200 Common Stock
GEQ

Gerald E Quirk

Chief Legal & Compliance Offic
Cambridge, MA

Track Institutional and Insider Activities on SYRS

Follow Syros Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SYRS shares.

Notify only if

Insider Trading

Get notified when an Syros Pharmaceuticals, Inc. insider buys or sells SYRS shares.

Notify only if

News

Receive news related to Syros Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SYRS